17.02.2014 • News • AZ Electronic Materials • AZ Electronics • Dede Willams

Merck Extends Offer for AZ Electronics Until Mid-March

Merck KGaA has for the fourth time extended its offer for AZ Electronic Materials. The German chemical and pharmaceuticals company said more additional time is needed to allow the Chinese antitrust authority MOFCOM to review filings. The newest deadline for AZ shareholders to accept the offer is March 14.

Merck said discussions with China's ministry of commerce have "proceeded constructively." Separately, it said antitrust clearance in Japan was granted on Feb. 10. Authorities in Germany, Taiwan and the U.S. have already given the green light.

As of Feb. 28, AZ shareholders had tendered stock worth around 64.03% of the company's existing share capital, Merck said.

Interview

Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Innovation Pitch

Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

Digitalization in the Chemical Industry

IMCD Deutschland GmbH

Fostering Innovation and Collaboration

Ecocool GmbH

Transport Logistic: Ecocool Presents Packaging Solutions for Pharmaceutical Transports

Evonik Industries AG

Maximize the Potential of Spent Hydroprocessing Catalysts

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

22.04.2025 • News

Merck Extends Offer for AZ Electronics Until Mid-March